Michael D. O'Halleran and Patrick S. Miles Elected to

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Michael D. O'Halleran and Patrick S. Miles Elected to NuVasive Board of Directors

SAN DIEGO, CA --(Marketwired - August 01, 2016) - NuVasive, Inc. ( NASDAQ : NUVA ), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced the appointment of Mike O'Halleran and Pat Miles to the Company's Board of Directors effective August 1, 2016. Mr. O'Halleran will serve as an independent director of the Company and member of the Board's Audit Committee. Mr. Miles currently serves as president and chief operating officer (COO) of NuVasive, Inc. and is a member of the Company's executive management team. Mr. Miles will serve as a non-independent member of the Board.

"We are pleased to welcome Mike and Pat to our Board of Directors as we work to advance the long-term strategic goals of NuVasive. Mike and Pat are extremely accomplished leaders who bring a wealth of experience and judgment to our Board," said Gregory T. Lucier, chairman and chief executive officer of NuVasive, Inc. "Mike's extensive business experience and Pat's deep understanding of the dynamics of the spine industry will complement the skills of our current Board and add value to the future of the Company."

With more than 40 years of business experience, Mr. O'Halleran currently serves as the executive chairman of Aon Benfield and senior vice president of Aon, plc, a provider of risk management, insurance and consulting services. Mr. O'Halleran joined the Aon group of companies in 1987 to lead its reinsurance division and since that time, has served in several significant management positions including president and chief operating officer of Aon Corporation, and since August 2007, as the executive chairman of Aon Benfield. Prior to joining Aon, he was a senior executive with well-known companies in the insurance industry. Mr. O'Halleran brings extensive healthcare and medical device governance experience, having been a long-standing director of Cardinal Health and later CareFusion. Mr. O'Halleran has a degree in Accounting and Finance from the University of Wisconsin-Whitewater.

As an orthopedic and spine industry veteran with more than 25 years' experience, Mr. Miles' appointment to the Board reflects the impact he brings to the future of NuVasive. Mr. Miles has been with NuVasive since 2001, and has held multiple roles with increasing responsibility in the areas of operations, research, surgeon education, product development, and marketing. In 2015, he was appointed president and COO, responsible for leadership of NuVasive's global products and services, as well as operational duties, including customer fulfillment, manufacturing, supply chain management and quality engineering. Prior to joining NuVasive, he held positions at Medtronic Sofamor Danek and Smith & Nephew. Mr. Miles received a B.S. in Finance from Mercer University.

About NuVasive

NuVasive, Inc. ( NASDAQ : NUVA ) is a world leader in minimally invasive, procedurally-integrated spine solutions. From complex spinal deformity to degenerative spinal conditions, NuVasive is transforming spine surgery with innovative technologies designed to deliver reproducible and clinically proven surgical outcomes. NuVasive's highly differentiated, procedurally-integrated solutions include access instruments, implantable hardware and software systems for surgical planning and reconciliation technology that centers on achieving the global alignment of the spine. With $811 million in revenues (2015), NuVasive has an approximate 1,900 person workforce in more than 40 countries around the world. For more information, please visit nuvasive.com.

Forward-Looking Statements

NuVasive cautions you that statements included in this news release that are not a description of historical facts are forward-looking statements that involve risks, uncertainties, assumptions and other factors which, if they do not materialize or prove correct, could cause NuVasive's results to differ materially from historical results or those expressed or implied by such forward-looking statements. The potential risks and uncertainties which contribute to the uncertain nature of these statements include, among others, risks associated with acceptance of the Company's surgical products and procedures by spine surgeons, development and acceptance of new products or product enhancements, clinical and statistical verification of the benefits achieved via the use of NuVasive's products (including the iGA™ platform), the Company's ability to effectually manage inventory as it continues to release new products, its ability to recruit and retain management and key personnel, and the other risks and uncertainties described in NuVasive's news releases and periodic filings with the Securities and Exchange Commission. NuVasive's public filings with the Securities and Exchange Commission are available at www.sec.gov . NuVasive assumes no obligation to update any forward-looking statement to reflect events or circumstances arising after the date on which it was made.

Investor Contact: Suzanne Hatcher NuVasive, Inc. 858-458-2240 Email contact Media Contact: Michael Farrington NuVasive, Inc. 858-909-1940 Email contact

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 433

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 382

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
Breakthrough T1D Pushes Global T1D Awareness Forward

Updated Category News Views 231

Shining a Light on T1D with Global Efforts In a world where a change in lifestyle can happen at the drop of a hat, Breakthrough T1D is making waves by expanding their global "See T1D" campaign in honor of World Diabetes Day. This isn't your run-of-the-mill awareness push—this is about propelling an understanding of what life truly entails for those living with type 1...

Continue Reading
PASCAL's Holiday Gift Edit: Timeless Watches Shine

Updated Category News Views 338

Fresh Sparkle for the Holidays Well, here we are again, staring down the barrel of another holiday season. And what do you know, PASCAL is out with its 2026 Holiday Gift Edit, like clockwork. This is the kind of stuff they’re good at—capturing a moment, slapping some color on it, and calling it a game-changer. Launching on November 14, this edit nods to their Timeless...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 271

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 445

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading
EFICYENT Ventures to Connect at Singapore FinTech Fest

Updated Category News Views 204

Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 155

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 212

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
HONGQI's EHS4 Launch in Europe: Bridging East and West

Updated Category News Views 190

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Continue Reading

Top 5 Most Recently Viewed Articles

Top Growth Stocks to Consider: Nvidia, Super Micro, Royal Caribbean

Updated Category News Views 255

Exploring High-Performing Stocks After the Pandemic Following the pandemic, the stock market has experienced a remarkable recovery, largely driven by advancements in artificial intelligence and a resurgence in travel demand. Among the standout performers in this landscape, three companies have particularly excelled, showcasing impressive growth potential. Let’s delve...

Continue Reading
Dandy® Celery Innovates Back-to-School Snacking Options

Updated Category News Views 58

Dandy® Celery Offers Innovative Snacking for Back-to-School Dandy® Produce, a leading name in fresh celery, is here to support families as they navigate back-to-school routines. They provide a variety of quick and healthy meal and snack options. Their fresh-cut celery sticks are a perfect addition to school lunches, afterschool snacks, and even quick sides for busy...

Continue Reading
Nebius Group: A Thriving Alternative in AI Computing Sector

Updated Category News Views 453

Nebius Group N.V. Takes on Major Hyperscalers Analyst Alexander Platt from D.A. Davidson & Co. recently launched coverage on Nebius Group N.V. (NASDAQ: NBIS) with a Buy rating, showcasing a promising future as an alternative to leading hyperscalers in the AI computing space. Transforming AI Computing with Transparent Solutions The ever-evolving demand for AI solutions has...

Continue Reading
Innovative Waste Tracking Enhances Hospital Sustainability Efforts

Updated Category News Views 123

Enhancing Hospital Sustainability Through Waste Management In today's driven healthcare landscape, managing waste effectively is more important than ever. remedi, a notable player in the regulated medical waste processing sector, has recently announced an expansion of its waste tracking and reporting capabilities. This initiative aims to assist hospitals in gaining...

Continue Reading
Insights on Core Molding Technologies Stock Movements

Updated Category News Views 148

Core Molding Technologies Stock Activity Overview Recently, there’s been significant trading activity surrounding Core Molding Technologies Inc (NYSEMKT:CMT). Renee R. Anderson, the Executive Vice President of Human Resources, sold shares valued at $32,094. This sale involved 1,783 shares, each priced at $18.00, which caught the attention of both investors and market...

Continue Reading